AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30125510 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaplan-Meier overall survival data from the CLEOPATRA trial
Number of subjects: 0
Study 30125510 — intervention group
Group type: EXPERIMENTAL
Intervention: Parametric functions fitted to survival data
Number of subjects: 0
Study 30125510 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim analyses of clinical trial data
Number of subjects: 0
Study 26475680 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity program
Number of subjects: 0
Study 25277416 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy based exercise intervention (individualised program of calf muscle exercises and walking, 12 weeks duration, includes up to six telephone delivered behavioural coaching and goal setting sessions, supported by written materials, a pedometer, and two follow-up booster calls)
Number of subjects: 0
Study 25277416 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care as recommended by evidence based guidelines, supported by a generic information sheet encouraging lower limb exercises, a pedometer for self-management, and phone calls at the same time points as the intervention group)
Number of subjects: 0
Study 25277416 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy based exercise intervention
Number of subjects: 0
Study 25277416 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 21874629 — intervention group
Group type: EXPERIMENTAL
Intervention: Coagulation with the new semiautomated VITE-function of VISULAS 532 s (pulse duration 20 ms, power 286 mW)
Number of subjects: 101
Study 21874629 — intervention group
Group type: COMPARATOR
Intervention: Conventional single-spot coagulation (pulse duration 100-150 ms, power 157 mW)
Number of subjects: 101
Study 20385894 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 91
Study 20385894 — intervention group
Group type: COMPARATOR
Intervention: Infiltration, physiotherapy, or medication
Number of subjects: 91
Study 20385894 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 91
Study 17368065 — intervention group
Group type: EXPERIMENTAL
Intervention: LNAA supplementation
Number of subjects: 16
Study 17368065 — intervention group
Group type: COMPARATOR
Intervention: Medical product (with or without LNAA supplements)
Number of subjects: 16
Study 15837702 — intervention group
Group type: EXPERIMENTAL
Intervention: OXAFAFU high dose (hd)
Number of subjects: 274
Study 15837702 — intervention group
Group type: EXPERIMENTAL
Intervention: OXAFAFU low dose (ld)
Number of subjects: 274
Study 15837702 — intervention group
Group type: EXPERIMENTAL
Intervention: OXAFAFU (both doses)
Number of subjects: 274
Study 11754196 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids
Number of subjects: 0
Study 11754196 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine and cyclosporine
Number of subjects: 0
Study 11754196 — intervention group
Group type: COMPARATOR
Intervention: Other immunosuppressives
Number of subjects: 0
Study 9696222 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrogen
Number of subjects: 68
Study 9696222 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous combined estrogen and progestogen
Number of subjects: 68
Study 9696222 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous estrogen
Number of subjects: 68
Study 9696222 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 68
Study 8073391 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant thrombomodulin analog (TME)
Number of subjects: 0
Study 8073391 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hirudin (r-HIR)
Number of subjects: 0
Study 8073391 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin sodium (HEP)
Number of subjects: 0
Study 8073391 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 0
Study 2563788 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis-B vaccine + 7 monthly injections of HB immunoglobulin (HBIg)
Number of subjects: 235
Study 2563788 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis-B vaccine + 1 HBIg injection at birth
Number of subjects: 235
Study 2563788 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis-B vaccine only
Number of subjects: 235
Study 2563788 — intervention group
Group type: COMPARATOR
Intervention: Placebo for both vaccine and HBIg
Number of subjects: 235
Study 31006122 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular triamcinolone acetonide (20 mg in both tarsocrural joints, total 40 mg/horse)
Number of subjects: 10
Study 31006122 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular triamcinolone acetonide (40 mg)
Number of subjects: 10
Study 29797689 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stimuli at 48-49-48 °C (traditional OA-paradigm)
Number of subjects: 24
Study 29797689 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimuli at 150%-180%-150% of the electrical pain perception (EPP) threshold
Number of subjects: 24
Study 29797689 — intervention group
Group type: COMPARATOR
Intervention: CONTROL-STIM (30 s constant heat at 48 °C and electrical stimuli at 150% of the EPP)
Number of subjects: 24
Study 27060379 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine (Danish strain 1331 SSI)
Number of subjects: 4262
Study 27060379 — intervention group
Group type: COMPARATOR
Intervention: No vaccine (control group)
Number of subjects: 4262
Study 24675145 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings
Number of subjects: 153
Study 24675145 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 153
Study 22969980 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 4000 (20 g/day)
Number of subjects: 216
Study 22969980 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (15 ml/day)
Number of subjects: 216
Study 20624256 — intervention group
Group type: EXPERIMENTAL
Intervention: Large breakfast consumption
Number of subjects: 32
Study 20624256 — intervention group
Group type: COMPARATOR
Intervention: Fasting (control)
Number of subjects: 32
Study 18756471 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal albumin dialysis (ECAD)
Number of subjects: 22
Study 18756471 — intervention group
Group type: COMPARATOR
Intervention: Control group (SMT)
Number of subjects: 22
Study 16021966 — intervention group
Group type: EXPERIMENTAL
Intervention: Posture correction exercises in physical education classes (n=200)
Number of subjects: 413
Study 16021966 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=213)
Number of subjects: 413
Study 12382293 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole with subtalar strapping (n = 42)
Number of subjects: 88
Study 12382293 — intervention group
Group type: COMPARATOR
Intervention: Sock-type ankle support (n = 46)
Number of subjects: 88
Study 9298559 — intervention group
Group type: COMPARATOR
Intervention: Short rest interval (40 seconds)
Number of subjects: 15
Study 9298559 — intervention group
Group type: EXPERIMENTAL
Intervention: Long rest interval (160 seconds)
Number of subjects: 15
Study 9298559 — intervention group
Group type: COMPARATOR
Intervention: Both groups (short and long rest intervals)
Number of subjects: 15
Study 1775598 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine at 20 mg/day for at least 8 weeks
Number of subjects: 79
Study 1775598 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (29 individuals of similar age)
Number of subjects: 79
Study 1775598 — intervention group
Group type: COMPARATOR
Intervention: Younger depressed patients (31 individuals)
Number of subjects: 79
Study 7340507 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic encouragement and community access procedure
Number of subjects: 20
Study 7340507 — intervention group
Group type: COMPARATOR
Intervention: Standard referral procedure
Number of subjects: 20
Study 30487209 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtherapeutic CPAP
Number of subjects: 41
Study 30487209 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic CPAP
Number of subjects: 41
Study 25349205 — intervention group
Group type: EXPERIMENTAL
Intervention: AST-120 (9 g/d)
Number of subjects: 2035
Study 25349205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2035
Study 25208597 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 20 mg tadalafil
Number of subjects: 30
Study 25208597 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous dose of 5 mg tadalafil each morning for seven consecutive days
Number of subjects: 30
Study 22647399 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus cognitive behavioral therapy sessions, psycho-educational sessions for family members, and case management
Number of subjects: 400
Study 22647399 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 400
Study 19154478 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal decortication with wadding using perirenal fat tissue (RDCW)
Number of subjects: 40
Study 19154478 — intervention group
Group type: COMPARATOR
Intervention: Simple retroperitoneal decortication (SRD)
Number of subjects: 40
Study 19154478 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (RDCW and SRD)
Number of subjects: 40
Study 17900265 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ebastine
Number of subjects: 22
Study 15385360 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (ITS)
Number of subjects: 40
Study 15385360 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sufentanil (IVS)
Number of subjects: 40
Study 11490343 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) biopsy
Number of subjects: 961
Study 11490343 — intervention group
Group type: EXPERIMENTAL
Intervention: Breslow thickness, Clark level, ulceration, and patient age
Number of subjects: 961
Study 30935461 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flux hemodialysis (HD)
Number of subjects: 7
Study 30935461 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodiafiltration (HDF)
Number of subjects: 7
Study 7649972 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 817
Study 7649972 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 817
Study 7649972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 817
Study 2375294 — intervention group
Group type: EXPERIMENTAL
Intervention: Overlap of lactation and pregnancy
Number of subjects: 504
Study 2375294 — intervention group
Group type: EXPERIMENTAL
Intervention: Short recuperative periods (less than 6 months)
Number of subjects: 504
Study 2375294 — intervention group
Group type: EXPERIMENTAL
Intervention: Energetic stresses of overlap and short recuperative periods
Number of subjects: 504
Study 518806 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral preparation of dichloralphenazone and paracetamol (Paedosed)
Number of subjects: 562
Study 518806 — intervention group
Group type: COMPARATOR
Intervention: i.m. morphine and atropine
Number of subjects: 562
Study 31644357 — intervention group
Group type: EXPERIMENTAL
Intervention: pTVG-HP co-administered intradermally with 200 μg GM-CSF adjuvant
Number of subjects: 99
Study 31644357 — intervention group
Group type: COMPARATOR
Intervention: 200 μg GM-CSF alone
Number of subjects: 99
Study 28235536 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (group U, n=32)
Number of subjects: 64
Study 28235536 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (group C, n=32)
Number of subjects: 64
Study 25930144 — intervention group
Group type: EXPERIMENTAL
Intervention: SG1002 (400 mg)
Number of subjects: 15
Study 25930144 — intervention group
Group type: EXPERIMENTAL
Intervention: SG1002 (400 mg and 800 mg)
Number of subjects: 15
Study 25930144 — intervention group
Group type: EXPERIMENTAL
Intervention: SG1002 (all doses)
Number of subjects: 15
Study 25930144 — intervention group
Group type: EXPERIMENTAL
Intervention: SG1002
Number of subjects: 15
Study 23672597 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiangtang Xiaozhi (3 capsules three times daily for 16 weeks)
Number of subjects: 71
Study 23672597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 22086220 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer disease (AD)
Number of subjects: 2963
Study 22086220 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular dementia (VAD)
Number of subjects: 2963
Study 22086220 — intervention group
Group type: EXPERIMENTAL
Intervention: Parkinson disease dementia
Number of subjects: 2963
Study 22086220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia with Lewy bodies (DLB)
Number of subjects: 2963
Study 22086220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed dementias (AD/VAD and AD/DLB)
Number of subjects: 2963
Study 22086220 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall dementia types
Number of subjects: 2963
Study 22086220 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild diagnoses
Number of subjects: 2963
Study 19815583 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative requesting
Number of subjects: 201
Study 19815583 — intervention group
Group type: COMPARATOR
Intervention: Routine requesting
Number of subjects: 201
Study 17427065 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS)
Number of subjects: 98
Study 17427065 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiography (ERC)
Number of subjects: 98
Study 15482360 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 microg/kg/min GTN infusion
Number of subjects: 32
Study 15482360 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 32
Study 11490238 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg exisulind twice daily for 12 months
Number of subjects: 96
Study 11490238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 9550628 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-inhibitors
Number of subjects: 1715
Study 9550628 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 1715
Study 9550628 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 1715
Study 9550628 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 1715
Study 9550628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1715
Study 9721149 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced distal adenoma
Number of subjects: 981
Study 9721149 — intervention group
Group type: COMPARATOR
Intervention: Nonadvanced distal adenoma
Number of subjects: 981
Study 9721149 — intervention group
Group type: COMPARATOR
Intervention: Not performing colonoscopy in nonadvanced distal adenoma
Number of subjects: 981
Study 2718479 — intervention group
Group type: EXPERIMENTAL
Intervention: Clidinium bromide 5 mg + Magnesium citrate
Number of subjects: 40
Study 2718479 — intervention group
Group type: COMPARATOR
Intervention: Clidinium bromide 5 mg + Placebo liquid
Number of subjects: 40
Study 2718479 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo capsule + Magnesium citrate
Number of subjects: 40
Study 2718479 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule + Placebo liquid
Number of subjects: 40
Study 340138 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg mefenamic acid
Number of subjects: 48
Study 340138 — intervention group
Group type: EXPERIMENTAL
Intervention: 32.5 mg dextropropoxyphene hydrochloride plus 325 mg paracetamol
Number of subjects: 48
Study 29474302 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab plus prompt laser
Number of subjects: 335
Study 29474302 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab plus deferred laser
Number of subjects: 335
Study 27861249 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (60% peak oxygen uptake, 30 min)
Number of subjects: 27
Study 27861249 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG) exercise (30% maximum voluntary contraction, 4×2 min bilateral)
Number of subjects: 27
Study 27861249 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (8 weeks)
Number of subjects: 27
Study 27861249 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG) training (8 weeks)
Number of subjects: 27
Study 27861249 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control
Number of subjects: 27
Study 25452071 — intervention group
Group type: EXPERIMENTAL
Intervention: Early sustained reduction
Number of subjects: 943
Study 25452071 — intervention group
Group type: EXPERIMENTAL
Intervention: Late sustained reduction
Number of subjects: 943
Study 25452071 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary reduction
Number of subjects: 943
Study 25452071 — intervention group
Group type: COMPARATOR
Intervention: No reduction
Number of subjects: 943
Study 24570979 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaster impressions
Number of subjects: 38
Study 24570979 — intervention group
Group type: COMPARATOR
Intervention: Splinted vinyl polysiloxane (splinted‐VPS) impressions
Number of subjects: 38
Study 21148048 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterolane maleate 50 mg
Number of subjects: 229
Study 21148048 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterolane maleate 100 mg
Number of subjects: 229
Study 21148048 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterolane maleate 200 mg
Number of subjects: 229
Study 21148048 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination with piperaquine phosphate
Number of subjects: 229
Study 19492313 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of methylphenidate (MPH)
Number of subjects: 43
Study 16440537 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifamily Asthma Group Treatment (MFAGT)
Number of subjects: 24
Study 16440537 — intervention group
Group type: COMPARATOR
Intervention: Standard Psychoeducational Asthma Intervention
Number of subjects: 24
Study 16440537 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychoeducational intervention)
Number of subjects: 24
Study 15345098 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 350
Study 15345098 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 350
Study 15345098 — intervention group
Group type: COMPARATOR
Intervention: Advice and exercise
Number of subjects: 350
Study 11759865 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP plus minocycline microspheres
Number of subjects: 748
Study 11759865 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 748
Study 11759865 — intervention group
Group type: COMPARATOR
Intervention: SRP plus vehicle
Number of subjects: 748
Study 9222805 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice a day for ten days
Number of subjects: 70
Study 9222805 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline plus ceftriaxone (1 g in two doses for one day)
Number of subjects: 70
Study 9222805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 7660023 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits to mothers and babies at 5, 10, and 20 days after birth.
Number of subjects: 450
Study 7660023 — intervention group
Group type: COMPARATOR
Intervention: Non-visited control group.
Number of subjects: 450
Study 7660023 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits to mothers and babies.
Number of subjects: 450
Study 2894921 — intervention group
Group type: EXPERIMENTAL
Intervention: IV metoprolol and IV streptokinase (group 1)
Number of subjects: 25
Study 2894921 — intervention group
Group type: COMPARATOR
Intervention: IV metoprolol (group 2)
Number of subjects: 25
Study 31873098 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent bright light (IBL) (9,500 lux) for 6.5 hours
Number of subjects: 21
Study 31873098 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous bright light (CBL) (9,500 lux) for 6.5 hours
Number of subjects: 21
Study 31873098 — intervention group
Group type: COMPARATOR
Intervention: Continuous dim light (VDL) (1 lux) for 6.5 hours
Number of subjects: 21
Study 29231617 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication combined with acupuncture
Number of subjects: 0
Study 29231617 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture control group
Number of subjects: 0
Study 25420776 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestrinone combined with ultrasound-guided aspiration and ethanol injection
Number of subjects: 68
Study 25420776 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided aspiration and ethanol injection
Number of subjects: 68
Study 21685354 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergent literacy intervention consisting of eighteen 30‐min lessons delivered twice weekly to small groups of children.
Number of subjects: 640
Study 21700817 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher net endogenous acid production (NEAP)
Number of subjects: 462
Study 21700817 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 4/5 CKD
Number of subjects: 462
Study 21700817 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage 2/3 CKD
Number of subjects: 462
Study 19332850 — intervention group
Group type: COMPARATOR
Intervention: Endorectal MR imaging alone
Number of subjects: 134
Study 19332850 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined endorectal MR imaging and MR spectroscopic imaging
Number of subjects: 134
Study 16542292 — intervention group
Group type: EXPERIMENTAL
Intervention: Alequel (autologous colonic proteins)
Number of subjects: 31
Study 16542292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 12740543 — intervention group
Group type: EXPERIMENTAL
Intervention: CaCO(3)/MFP dentifrice
Number of subjects: 10
Study 12740543 — intervention group
Group type: COMPARATOR
Intervention: SiO(2)/MFP dentifrice
Number of subjects: 10
Study 12740543 — intervention group
Group type: COMPARATOR
Intervention: Negative control (brushing without dentifrice)
Number of subjects: 10
Study 11098560 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD)
Number of subjects: 0
Study 11098560 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone or new class III agents (e.g., Dofetilide)
Number of subjects: 0